Source: International Congress 2017 – ILDs: clinical problems
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. Cameli (Certaldo, Italy). Exhaled nitric oxide in idiopathic and non-idiopathic interstitial lung disease. 878

Member's Comments

No comment yet.

Related content which might interest you: Evaluation of exhaled nitric oxide in idiopathic interstitial lung diseases Source: International Congress 2015 – IIPs: orphan Year: 2015 Exhaled nitric oxide in patients with idiopathic pulmonary fibrosis and pulmonary hypertension Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology? Year: 2008 Fractional exhaled nitric oxide in chronic obstructive pulmonary disease Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease Year: 2015 Severity of scleroderma lung disease is related to alveolar concentration of nitric oxide Source: Eur Respir J 2007; 30: 26-30 Year: 2007 Fractional exhaled nitric oxide in patients with chronic obstructive pulmonary disease Source: International Congress 2019 – FeNO in airway diseases and asthma-COPD overlap identification Year: 2019 Exhaled nitric oxide increases in chronic eosinophilic pneumonia Source: Eur Respir J 2002; 20: Suppl. 38, 509s Year: 2002 Exhaled nitric oxide and pulmonary function in children with sickle cell disease Source: Annual Congress 2010 - Paediatric asthma, rhinitis and management Year: 2010 Fractional exhaled nitric oxide levels in patients with non-cystic fibrosis bronchiectasis Source: International Congress 2016 – Asthma, bronchiectasis, and the risk factors for respiratory morbidity Year: 2016 Exhaled nitric oxide is not reduced in infants with cystic fibrosis Source: Eur Respir J 2006; 27: 350-354 Year: 2006 Nitric oxide production by the alveolar compartment of the lungs in cirrhotic patients Source: Eur Respir J 2009; 34: 138-144 Year: 2009 Bronchial and alveolar exhaled nitric oxide as a marker of systemic involvement in patients with Crohn‘s disease Source: Annual Congress 2011 - Role of the biomarkers in airway diseases Year: 2011 Exhaled nitric oxide levels in patients with pulmonary hypertension Source: International Congress 2016 – Pulmonary hypertension: the clinic II Year: 2016 Exhaled nitric oxide in stable adult cystic fibrosis patients, during exacerbation and following CFTR-modifying treatment Source: Eur Respir J, 53 (5) 1802259; 10.1183/13993003.02259-2018 Year: 2019 Reduced exhaled nitric oxide in infants with cystic fibrosis Source: Eur Respir J 2004; 24: Suppl. 48, 384s Year: 2004 Fractional exhaled nitric oxide for eosinophilic inflammation in stable COPD Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers Year: 2017 An increase in exhaled nitric oxide is not associated with activity in pulmonary sarcoidosis Source: Eur Respir J 2004; 24 : 609-614 Year: 2004 Exhaled nitric oxide in the differential diagnosis of chronic cough Source: Annual Congress 2007 - Noninvasive evaluation of airway diseases Year: 2007 Exhaled nitric oxide in mustard airway disease Source: International Congress 2018 – Occupational and environmental lung diseases: influence on the airway and interstitium Year: 2018 Exhaled condensate of endothelin-1 and exhaled nitric oxide are increased in COPD patients with secondary pulmonary hypertension Source: Eur Respir J 2007; 30: Suppl. 51, 55s Year: 2007 Exhaled nitric oxide in respiratory diseases other than asthma Source: Eur Respir Monogr 2010; 49: 45-55 Year: 2010